Loading company details...
Beta
Latest Form 4 (Aug 10, 2026): Scott T. Rottinghaus (Chief Medical Officer): Tax Withholding of 1,467 shares, $19.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 10, 2026 | Scott T. Rottinghaus, Chief Medical Officer | Tax Withholding | 1,467 | $19.6K |
| Mar 13, 2026 | Terry Vance | Grant/Award | 20,000 | n/a |
| Mar 13, 2026 | Lesley Russell | Grant/Award | 20,000 | n/a |
| Mar 13, 2026 | Kristine Peterson | Grant/Award | 20,000 | n/a |
| Mar 13, 2026 | Yujiro S. Hata | Grant/Award | 20,000 | n/a |
| Mar 13, 2026 | Mark G. Foletta | Grant/Award | 20,000 | n/a |
| Mar 13, 2026 | Bruce L. A. Carter | Grant/Award | 20,000 | n/a |
| Feb 13, 2026 | Matthew Paul Kowalsky, Chief Legal Officer | Grant/Award | 1,318 | n/a |
| Feb 13, 2026 | Brendan Luu, Chief Business Officer | Grant/Award | 1,575 | n/a |
| Feb 13, 2026 | Tara Lynn Kieffer, Chief Product Strategy Officer | Grant/Award | 1,575 | n/a |